SAMJ: South African Medical Journal
Print version ISSN 0256-9574
HANEKOM, Willem A et al. SATVI: after 10 years closing in on a new and better vaccine to prevent tuberculosis. SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.6, pp. 438-441. ISSN 0256-9574.
The vision of the South African Tuberculosis Vaccine Initiative (SATVI) (http://www.satvi.uct.ac.za) is 'A World Without TB' and our mission is 'Innovative and high-quality TB vaccine research in Africa, to impact the global epidemic'. Over the last 10 years, our focus has been two-fold: first, clinical trials of BCG and of new candidate vaccines, and second, complementary research that addresses critical questions in tuberculosis (TB) vaccine development. SATVI is now widely regarded as the leading TB vaccine clinical research site in the world.